Skip to search.
 NZX 50 Up 0.25%
Streaming
Ticker Tape: On

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
13.79 Down 0.44(3.09%) 08:00
|After Hours : 13.87 Up 0.08 (0.58%) 10:26
Add to Portfolio
Prev Close:14.23
Open:14.18
Bid:13.82 x 600
Ask:14.20 x 1000
1y Target Est:25.64
Beta:4.2
Earnings Date:5 May - 9 May (Est.)
Day's Range:13.62 - 14.48
52wk Range:6.61 - 17.46
Volume:1,682,799
Avg Vol (3m):3,004,240
Market Cap:1.25b
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 3.09%1.25b
BAXDown 0.19%39.24b
SHPGUp 2.68%30.54b

Key Statistics

Forward P/E (1 yr):28.14
P/S (ttm):184.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Mar-14) :-0.08
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback